146 related articles for article (PubMed ID: 34126129)
21. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
Tucholski K; Deja G; Skała-Zamorowska E; Jarosz-Chobot P
Pediatr Endocrinol Diabetes Metab; 2009; 15(1):29-33. PubMed ID: 19454186
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70-180 mg/dL Versus Time-in-Tight-Range 70-140 mg/dL.
Beck RW; Raghinaru D; Calhoun P; Bergenstal RM
Diabetes Technol Ther; 2024 Mar; 26(3):151-155. PubMed ID: 37870460
[No Abstract] [Full Text] [Related]
24. [The appropriate cut-off point of time in range (TIR) for evaluating glucose control in type 2 diabetes mellitus].
Dai DJ; Lu JY; Zhang L; Shen Y; Mo YF; Lu W; Zhu W; Bao YQ; Zhou J
Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):2990-2996. PubMed ID: 33086449
[No Abstract] [Full Text] [Related]
25. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of association between time in range, a continuous glucose monitoring metric, and cardiac autonomic neuropathy in type 2 diabetes patients.
Karthikeyan A; Ramakrishna MP; Swamy NA; Latha AT
Ann Afr Med; 2024; 23(1):19-24. PubMed ID: 38358166
[TBL] [Abstract][Full Text] [Related]
27. Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia.
Kesavadev J; Misra A; Saboo B; Agarwal S; Sosale A; Joshi SR; Hussain A; Somasundaram N; Basit A; Choudhary P; Soegondo S
Diabetes Metab Syndr; 2022 Jan; 16(1):102345. PubMed ID: 34920199
[TBL] [Abstract][Full Text] [Related]
28. Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution.
Rodbard D
Diabetes Technol Ther; 2020 Jul; 22(7):492-500. PubMed ID: 31886733
[No Abstract] [Full Text] [Related]
29. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
Anderson SM; Buckingham BA; Breton MD; Robic JL; Barnett CL; Wakeman CA; Oliveri MC; Brown SA; Ly TT; Clinton PK; Hsu LJ; Kingman RS; Norlander LM; Loebner SE; Reuschel-DiVirglio S; Kovatchev BP
Diabetes Technol Ther; 2019 Jun; 21(6):356-363. PubMed ID: 31095423
[No Abstract] [Full Text] [Related]
30. Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy.
Rodbard D
Diabetes Technol Ther; 2021 Oct; 23(10):692-704. PubMed ID: 34086495
[TBL] [Abstract][Full Text] [Related]
31. The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Kim MY; Kim G; Park JY; Choi MS; Jun JE; Lee YB; Jin SM; Hur KY; Kim JH
Diabetes Technol Ther; 2021 Jun; 23(6):434-442. PubMed ID: 33523771
[No Abstract] [Full Text] [Related]
32. Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE.
Bergenstal RM; Hachmann-Nielsen E; Kvist K; Peters AL; Tarp JM; Buse JB
Diabetes Technol Ther; 2023 Jun; 25(6):378-383. PubMed ID: 37017470
[TBL] [Abstract][Full Text] [Related]
33. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
Uemura F; Okada Y; Torimoto K; Tanaka Y
Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
[TBL] [Abstract][Full Text] [Related]
34. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
35. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
36. Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes.
Al-Ozairi E; Irshad M; Taghadom E; Varghese A; Sojan L; Alkandari J
Front Endocrinol (Lausanne); 2023; 14():1120384. PubMed ID: 37020598
[TBL] [Abstract][Full Text] [Related]
37. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.
Gomez-Peralta F; Dunn T; Landuyt K; Xu Y; Merino-Torres JF
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32198165
[TBL] [Abstract][Full Text] [Related]
38. Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices".
Rodbard D
Diabetes Technol Ther; 2018 May; 20(5):325-334. PubMed ID: 29792750
[TBL] [Abstract][Full Text] [Related]
39. An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and compliance.
Horowitz ME; Kaye WA; Pepper GM; Reynolds KE; Patel SR; Knudson KC; Kale GK; Gutierrez ME; Cotto LA; Horowitz BS
Diabetes Res Clin Pract; 2021 Jul; 177():108876. PubMed ID: 34058303
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care.
Boscari F; Ferretto S; Cavallin F; Fadini GP; Avogaro A; Bruttomesso D
Acta Diabetol; 2022 Jul; 59(7):921-928. PubMed ID: 35416537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
